ARCHIVES

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

October 7, 1994

Therapeutic Vaccine May Fight Pancreatic Cancer

February 23, 2007

RTOG: Hormone Therapy Increases Survival When Combined With Radiation Therapy

July 29, 2011

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

April 1, 2005

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

February 20, 1998

Edelson To Step Down As Yale Center Director.

January 11, 2008